MOZISTOBART
UNII 67RJK4R3RW

Substance Identification & Data

This profile provides standardized clinical and technical data for Mozistobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 67RJK4R3RW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2852752-92-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

67RJK4R3RW

CAS Registry Number

2852752-92-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MOZISTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C206944

National Cancer Institute reference terminology for clinical and research data.

INN ID

12946

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mozistobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

AB-125

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-460) (VH (HOMO SAPIENS IGHV3-48*03 (89.8%) -(IGHD) -IGHJ4*01 (85.7%) Q120>R (115), CDR-IMGT (8.8.16) (26-33.51-58.97-112)) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14, G1V14-1 CH2 A1.3, A1.2, A1 (CH1 R120>K (220) (124-221), HINGE 1-15 (222-236), CH2 L1.3>A (240), L1.2>A (241), G1>A (243) (237-346), CH3 E12 (362), M14 (364) (347-451), CHS K2>DEL (452), FUSED 8-MER RPQGFGPP (453-460)) (124-460)), (226-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (87.4%) -IGKJ2*02 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153'), V101 (191') (108'-214')); DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHOK1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (240-ALANINE,241-ALANINE,243-ALANINE), ANTI-(HUMAN/MACACA FASCICULARIS SIALIC ACID-BINDING IG-LIKE LECTIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL AB-125 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE (RPQGFGPP), DISULFIDE WITH HUMAN-MUSCULUS MONOCLONAL AB-125 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, B-LYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY

MOZISTOBART

MOZISTOBART [INN]

External Clinical & Regulatory Resources

Previous UNII67RHC0R671

Next UNII67RM91WDHQ